Maintenance of Investigator's Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis

• Asıl Yazarlar: Lawrence F. Eichenfield (Yazar), Linda F. Stein Gold (Yazar), Charles Lynde (Yazar), Lyn Guenther (Yazar), Shoshana Greenberger (Yazar), Chia-Yu Chu (Yazar), Zara Ghodsi (Yazar), Bonnie Vlahos (Yazar), Paul Sanders (Yazar), Amy Cha (Yazar), Juliana M. Canosa (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Introduction Treatments for atopic dermatitis (AD) often fail to achieve lasting disease control. In the CrisADe CONTROL phase III study (ClinicalTrials.gov: NCT04040192), participants aged ≥ 3 months with mild to moderate AD treated with once-daily (QD) crisaborole, following initial treat...